໒(• ŏᴗŏ•)७ try KnowYourQuotes.com find the perfect quote

Phase III Iclaprim trial results 'bode very well' for Motif Bio, says Northland Capital's Alexandre

Free Button: Daily News
Free Button: Daily News

  Info

Description

Vadim Alexandre, head of research at Northland Capital Partners gives his view on Motif Bio Plc's (LON: MTFB, NASDAQ:MTFB) successful completion of a phase III clinical trial of its next-generation antibiotic, iclaprim.The REVIVE-1 global study assessed the drug’s ability to treat patients with acute bacterial skin and skin structure infections (ABSSSI).''We know [Iclaprim] kills bacteria in the petri dish, we now know from this trial that it works in humans and we also know from a previous phase III trial ... that it met its primary endpoint as well'', Alexandre says.''There's very good reason to believe that the drug works and there's nothing in these results that are red flags to say that it shouldn't work in the second trial''.

Tags

northland capital vadim alexandre motif bio iclaprim
  Email Video to Friends   Receive Emails for Similar Videos

Email:

  Repeat and Loop Video   Link to Video   Create Short URL  Publish Text About This Video   Share on Facebook, Twitter, and more
  See Recommended Videos For You
Old Cartoons on DVD. Visit and Bookmark: Cool90s.com!

Related

  The 'end of the marathon' for Motif Bio's Iclaprim   Amphion Innovations pinning hopes on Polarean Inc after Motif Bio success   Motif Bio on track to move forward with new drug application after Iclaprim success   'All good news' from Motif Bio's Phase III clinical trial of Iclaprim, says CEO Graham Lumsden   Motif Bio celebrates 'major milestone 'in antibiotic trial'   Dr. Marty on Letermovir for CMV after Bone Marrow Transplant   Motif Bio gearing up to present at major conference on infectious diseases   Dr. Ramalingam on FLAURA Findings in EGFR-Mutant NSCLC   Motif Bio keen for UK shareholder participation in New York investor meeting   Start of Phase III Episalvan trial 'a momentous time in the history of Amryt' says CFO Rory Nealon   FDA Approvals in ALL, Ovarian Cancer, Priority Review in CTCL, and sNDA Submitted in RCC   Dr. Ledermann on Phase III ARIEL3 Results in Ovarian Cancer   ASCEND-4: Upfront Ceritinib in ALK-Rearranged NSCLC   'This year will give us the results we've been waiting for', says Faron pharmaceuticals boss   Dr. Bekaii-Saab on Results of the IDEA Project for Colon Cancer   2016 AACR Annual Meeting Highlights   Immunotherapy for Management of Stage 3B NSCLC   IPL 10: KKR Vs KXIP: Punjab is playing very well, says Harbhajan Singh   Dr. von Minckwitz on Phase III Results of the APHINITY Trial for Breast Cancer   Adjuvant Therapy for HER2-Driven Breast Cancer   Dr. Moore on the NOVA Trial for Ovarian Cancer   T-DM1 Plus Pertuzumab in the MARIANNE Trial   Dr. Shaw on the Phase III Results of the ALEX Trial in NSCLC   Lupuzor safety profile 'holding up' - ImmuPharma's Tim McCarthy updates on Phase III study   Dr. Sandler on Docetaxel With Hormonal and Radiation Therapy in Prostate Cancer   Dr. Dummer on COMBI-AD Trial Results in BRAF-Mutant Melanoma   Dr. Hamid on Epacadostat Plus Pembrolizumab in Advanced Melanoma   Dr. Chiara Cremolini on Frontline FOLFOXIRI Plus Bevacizumab in mCRC   CALGB 80405 Trial Results in Metastatic Colorectal Cancer   Dr. Finn on the Phase III PALOMA-2 Trial in ER+ Breast Cancer   ImmuPharma’s McCarthy on phase III Lupuzor trials   'We have absolutely no side effect profile in Lupuzor at all' says ImmuPharma chairman   Phase III Ibrutinib Findings, Prostate Cancer Congress, and More   FDA Approval in MZL, Delay in Immunotherapy Combos in NSCLC, and 2017 GI Symposium Highlights   Federal Election 2015: 'Red Wave' sweeping Quebec   Strategic Minerals chief explains uptick in iron ore sales   Benjamin Netanyahu "baffled" by Obama's settlement criticism   Amryt Pharma chief looking to “unlock a large market opportunity”   Ergomed boss runs Proactive through 'very good results' from Phase II trial for insomnia treatment   Amryt Pharma 'delighted' to kick off Episalvan trial   Dr. von Minckwitz on the Safety Profile of the APHINITY Trial for HER2+ Breast Cancer   FDA Approval in Myeloma, Priority Review in ALL, and 2017 GU Cancers Symposium Highlights   Wallace: Spicer's resignation a blow for Priebus' standing   Interest in Ergomed's blood thickener 'significant' - CEO Miroslav Reljanovic   ALTA II Trial of Brigatinib in ALK-Rearranged NSCLC   Stan Wright: "Trial is going very well"   Dr. Finn on Significance of Phase III Findings of Lenvatinib in HCC   Dr. Montal on Molecular Predictors of Recurrence With Adjuvant Sorafenib in HCC   New NCI Director, Early Release of Prostate Cancer Data, Disappointing Findings in RCC, and More   COMBI-AD: Implications for Melanoma Patients   A New Standard for Stage 3 BRAF+ Melanoma   Accident d'un car de touristes sous le tunnel du pont Alexandre III: quatre blessés dont un grave   We Have Reached A Disturbing Milestone in Climate Change   ReNeuron CFO 'pleased' with reformulation of degenerative diseases treatment   [Webinar] MoveDMD: A Clinical Trial of Edasalonexent (CAT-1004) in Duchenne - June 2016   2016 results unveiled the hidden value within BATM, says boss   News 18 Investigates: Is there a looming teacher shortage?   Tough week for the South African economy   Food 4 Thought - Worker at rodent-poop-filled store makes stunning admittal   2015 AACR Annual Meeting Highlights   APHINITY Trial in HER2+ Breast Cancer   FDA Approval in Bladder Cancer, Breakthrough Therapy Designation in DLBCL, and More   Dr. Mirza on Niraparib Plus Bevacizumab Combo in Ovarian Cancer   Pharmaxis gets A$27M injection from Boehringer Ingelheim   UP Election 2017 Voting For Phase- III Begins In 69 Constituencies   Amryt Pharma to raise €15mln for drug to treat rare skin condition   Mini Slimline DirecTV HD Ka/Ku Satellite Dish   Video: Poll doesn't bode well for president in Maryland   Late-Stage Trials: Immunotherapy Combinations for NSCLC   Full FDA Approvals in Breast Cancer and Lung Cancer, Priority Reviews in ALL, and More   PARP Inhibitors for BRCA-Mutated TNBC   Amryt Pharma's Joe Wiley 'delighted' to soon begin Phase III EB Study   Unemployment numbers doesn't bode well for college graduates   Delhi Metro's Heritage Line shows the way to easy access   Kōpara ki Te Matatini: Muriwhenua

Popular Today

  Lockdown in Bengaluru: Day 2   I've been moved by everything going on in the world lately and I finally mustard up recording my first song to completion. It's a call for more love and compassion. Due to it's relation to global warming, police violence, covid, and police violence I felt it fit in politics.   New EV charging plaza in Delhi   Emmy Nominations 2020   Facebook, Google, Apple, Amazon CEOs testify before US House antitrust subcommittee   Police investigating south county apartment fire that left one dead   Man arrested after making scene about refusing to wear mask   Tony Hawk breaks down skateboarding’s legendary spots   SHOCKING Jeffrey Epstein and Ghislaine Maxwell Documents Released   Plus d'une centaine de migrants secourus accostent à Lampedusa | AFP   Railways To Revamp IRCTC Website: Check Out The New Features   Kyle Kulinski: Previewing The Hellish Future Of MSNBC In The Biden Era   Mangroves - Restoring the guardian forests   Dr. Khong on Endocrine Combinations in ER+/HER2- Breast Cancer   How slow motion works   Unemployment agency makes progress on delayed benefits, but many Oklahomans still waiting   Le crabe bleu, bête noire des pêcheurs albanais | AFP   Riots cases: LG Anil Baijal overturns Delhi cabinet's decision on lawyers' panel   Maple Leafs Practice - August 3, 2020   Make America White Again: Eddie Glaude on Trump and What James Baldwin Still Has to Teach Us   Families mark El Paso Walmart shooting anniversary   The fight for America's 51st state, explained   Amazon 2Q Earnings Smash Estimates   Les 10 images de la semaine (25-31 juillet) | AFP Photo   5 Rafale Fighter Jets land in India   Maple Leafs Post Game - August 2, 2020   AG William Barr Runs Into A Buzz Saw | Tim Black   Belgium fights COVID-19 surge   Why scientists are so worried about this glacier   Byeong Hun An shoots 4-under 66 | Round 3 | WGC-FedEx St. Jude   Aïd al-Adha : des célébrations marquées par la crise sanitaire | AFP   PM Modi to address nation on New Education Policy   Maple Leafs Morning Skate - August 2, 2020   Saint Louis Zoo's elephant calf has passed away   Are more parents considering homeschooling kids due to coronavirus?   Black Kids Crying On Ground, Wrongly Arrested (VIDEO)   This Breonna Taylor Update Will ENRAGE You!   The Other Outbreak: False & Misleading Claims   Protest against privatisation   Maple Leafs Practice - July 14, 2020   Wild For Life Journeys - Marine   CheckMate-9LA: Histology and Frontline Impact   Meet the First American Marxist: Joseph Weydemeyer   Education officials respond to Gov. Stitt’s pledge to provide personal protective equipment   60 ans après son indépendance, le Bénin tente de s'émanciper | AFP   Supreme Court bars registration of BS-IV vehicles till further orders   Dude, where's my Stimulus Check?   Seattle & Portland Activists: Protest Federal and City Police Crackdowns & Keep Focus on BLM Agenda   Back to school in Georgia brings caution and tears   Overwatch Summer Games 2020 - NEW Event Skins, Highlight Intros and More! | Hammeh   View All Today's Popular Videos